Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001821825-25-000055
Filing Date
2025-06-16
Accepted
2025-06-16 17:34:12
Documents
1
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750109646.html 4  
1 FORM 4 wk-form4_1750109646.xml 4 4382
  Complete submission text file 0001821825-25-000055.txt   5801
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Sharp Shalini (Reporting) CIK: 0001377202 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40235 | Film No.: 251051224

Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Issuer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)